Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial
Thomas M Churilla, Karla V Ballman, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Nature Communications
|
January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
Evanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Cancer
|
December 10, 2021
Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)
Jon C Tilburt, David Zahrieh, Joel E Pacyna, et al.
Nature Genetics
|
July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
American Journal of Epidemiology
|
July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking
Daniel H Lachance, Ping Yang, Derek R Johnson, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial
Thomas M Churilla, Karla V Ballman, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Nature Communications
|
January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
Evanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Cancer
|
December 10, 2021
Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)
Jon C Tilburt, David Zahrieh, Joel E Pacyna, et al.
Nature Genetics
|
July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
American Journal of Epidemiology
|
July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking
Daniel H Lachance, Ping Yang, Derek R Johnson, et al.
Page
of 14